Vincerx Pharma, Inc. Quarterly Operating Lease, Payments in USD from Q1 2021 to Q3 2024

Taxonomy & unit
us-gaap: USD
Description
Amount of cash outflow from operating lease, excluding payments to bring another asset to condition and location necessary for its intended use.
Summary
Vincerx Pharma, Inc. quarterly/annual Operating Lease, Payments history and growth rate from Q1 2021 to Q3 2024.
  • Vincerx Pharma, Inc. Operating Lease, Payments for the quarter ending September 30, 2024 was $330K, a 3.77% increase year-over-year.
  • Vincerx Pharma, Inc. Operating Lease, Payments for the twelve months ending September 30, 2024 was $1.31M, a 4.06% increase year-over-year.
  • Vincerx Pharma, Inc. annual Operating Lease, Payments for 2023 was $1.27M, a 21.2% increase from 2022.
  • Vincerx Pharma, Inc. annual Operating Lease, Payments for 2022 was $1.05M, a 176% increase from 2021.
Operating Lease, Payments, Trailing 12 Months (USD)
Operating Lease, Payments, Quarterly (USD)
Operating Lease, Payments, YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q3 2024 $1.31M $330K +$12K +3.77% Jul 1, 2024 Sep 30, 2024 10-Q 2024-11-12
Q2 2024 $1.3M $330K +$13K +4.1% Apr 1, 2024 Jun 30, 2024 10-Q 2024-08-08
Q1 2024 $1.28M $330K +$13K +4.1% Jan 1, 2024 Mar 31, 2024 10-Q 2024-05-14
Q4 2023 $1.27M $318K +$13K +4.26% Oct 1, 2023 Dec 31, 2023 10-K 2024-03-29
Q3 2023 $1.26M $318K +$13K +4.26% Jul 1, 2023 Sep 30, 2023 10-Q 2024-11-12
Q2 2023 $1.24M $317K +$98K +44.7% Apr 1, 2023 Jun 30, 2023 10-Q 2024-08-08
Q1 2023 $1.15M $317K +$98K +44.7% Jan 1, 2023 Mar 31, 2023 10-Q 2024-05-14
Q4 2022 $1.05M $305K Oct 1, 2022 Dec 31, 2022 10-K 2024-03-29
Q3 2022 $305K Jul 1, 2022 Sep 30, 2022 10-Q 2023-11-14
Q2 2022 $219K Apr 1, 2022 Jun 30, 2022 10-Q 2023-08-07
Q1 2022 $219K +$191K +682% Jan 1, 2022 Mar 31, 2022 10-Q 2023-05-11
Q1 2021 $28K Jan 1, 2021 Mar 31, 2021 10-Q 2022-05-12
* An asterisk sign (*) next to the value indicates that the value is likely invalid.